SPY396.92+7.29 1.87%
DIA318.84+6.42 2.05%
IXIC11,535.28+180.66 1.59%

Innate Pharma to Get $50 Million Milestone Payment as AstraZeneca Starts Dosing in Phase 3 Lung Cancer Trial

MT Newswires · 04/29/2022 00:07

Please log in to view news